CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Kiniksa Fiscal Q2 2024 Earnings Report - CapyFin

Kiniksa

KNSA · NASDAQ🇬🇧

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 24h Q3 2025 -2.88%Q2 2025 +12.32%Q1 2025 +20.54%Q4 2024 +0.46%Q3 2024 -16.60%Q2 2024 +17.81%Q1 2024 +4.44%Q4 2023 +1.20%Q3 2023 -3.44%Q2 2023 +35.21%Q1 2023 +24.23%Q4 2022 -5.63%Q3 2022 +8.58%Q2 2022 +17.25%Q1 2022 +5.10%Q4 2021 -6.81%Q3 2021 +45.81%Q2 2021 -1.39%Q1 2021 -8.96%Q4 2020 -6.30%Q3 2020 -5.92%Q2 2020 +0.83%Q1 2020 -6.95%Q4 2019 -0.67%Q3 2019 +15.69%Q2 2019 -2.37%Q1 2019 +8.24%Q4 2018 -6.07%Q3 2018 +11.87%Q2 2018 +1.68%Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017

Jul 23, 2024

•

Jun 30, 2024

Kiniksa Q2 2024 Earnings Report

Kiniksa announced financial results for the quarter ended June 30, 2024.

Key Takeaways

Kiniksa Pharmaceuticals International, plc announced its financial results for the quarter ended June 30, 2024.

Previous year: $71.5M

Previous year: -$0.02

Previous year: $49.8M

Cash and Equivalents

Previous year: $113M

Previous year: -$3.78M

Previous year: $484M

Kiniksa

Unlock previous datapoints

Kiniksa

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis